Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation

Matthew A Spinelli^{1

2}, Susan P Buchbinder^{1

2

3}

Affiliations

¹ Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA.
² Department of Medicine, University of California, San Francisco, California, USA.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.

PMID: 31509603
PMCID: PMC7384308
DOI: 10.1093/cid/ciz896

Comment

Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation

Matthew A Spinelli et al. Clin Infect Dis. 2020.

. 2020 Jul 27;71(3):583-585.

doi: 10.1093/cid/ciz896.

Authors

Matthew A Spinelli^{1

2}, Susan P Buchbinder^{1

2

3}

Affiliations

¹ Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA.
² Department of Medicine, University of California, San Francisco, California, USA.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.

PMID: 31509603
PMCID: PMC7384308
DOI: 10.1093/cid/ciz896

No abstract available

Keywords: HIV; MSM; PrEP; Pre-exposure prophylaxis; persistence.

PubMed Disclaimer

Comment on

Pre-exposure Prophylaxis Uptake and Discontinuation Among Young Black Men Who Have Sex With Men in Atlanta, Georgia: A Prospective Cohort Study.
Serota DP, Rosenberg ES, Sullivan PS, Thorne AL, Rolle CM, Del Rio C, Cutro S, Luisi N, Siegler AJ, Sanchez TH, Kelley CF. Serota DP, et al. Clin Infect Dis. 2020 Jul 27;71(3):574-582. doi: 10.1093/cid/ciz894. Clin Infect Dis. 2020. PMID: 31499518 Free PMC article.

Cited by

Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques.
Xiao P, Gumber S, Marzinke MA, Hoang T, Myers R, Date AA, Hanes J, Ensign LM, Wang L, Rohan LC, Cone R, Fuchs EJ, Hendrix CW, Villinger F. Xiao P, et al. JCI Insight. 2022 Dec 8;7(23):e161577. doi: 10.1172/jci.insight.161577. JCI Insight. 2022. PMID: 36477356 Free PMC article.
Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States.
Rogers BG, Sosnowy C, Zanowick-Marr A, Chan PA, Mena LA, Patel RR, Goedel WC, Arnold T, Chu C, Galipeau D, Montgomery MC, Curoe K, Underwood A, Villalobos J, Gomillia C, Nunn AS. Rogers BG, et al. BMC Infect Dis. 2022 Aug 5;22(1):673. doi: 10.1186/s12879-022-07658-y. BMC Infect Dis. 2022. PMID: 35931953 Free PMC article.
PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States.
McNulty MC, Kerman J, Devlin SA, Pyra M, Rusie L, Curoe K, Thompson L, Mason JA, Friedman EE, Uvin AZ, Brown CH, Schneider J, Patel R. McNulty MC, et al. AIDS Educ Prev. 2023 Jun;35(3):235-246. doi: 10.1521/aeap.2023.35.3.235. AIDS Educ Prev. 2023. PMID: 37410372 Free PMC article.
Could disparities in PrEP uptake limit the public health benefit?
Keen P, Bavinton BR. Keen P, et al. Lancet Public Health. 2020 Sep;5(9):e467-e468. doi: 10.1016/S2468-2667(20)30183-3. Lancet Public Health. 2020. PMID: 32888440 Free PMC article. No abstract available.
Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project.
Levy L, Peterson JM, Kudrick LD, Chohan B, Bosek E, Mukui I, Mugambi M, Masyuko S, Mugurungi O, Ndlovu N, Mahaka I, Dunbar M, Hettema A, Kuwengwa RAP, Matse S, Mullick S, Greener L, O'Connor C, Pillay D, Fawzy M, Mellors JW, Parikh UM; Global Evaluation of Microbicide Sensitivity (GEMS) project. Levy L, et al. Glob Health Sci Pract. 2022 Apr 29;10(2):e2100122. doi: 10.9745/GHSP-D-21-00122. Print 2022 Apr 28. Glob Health Sci Pract. 2022. PMID: 35487541 Free PMC article.

See all "Cited by" articles

References

1. Grant RM, Lama JR, Anderson PL, et al. ; iPrEx Study Team Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587–99. - PMC - PubMed
1. Grulich AE, Guy R, Amin J, et al. ; Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) research group Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV 2018; 5:e629–37. - PubMed
1. Sullivan PS, Giler RM, Mouhanna F, et al. . Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Ann Epidemiol 2018; 28:833–40. - PMC - PubMed
1. Liu AY, Cohen SE, Vittinghoff E, et al. . Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med 2016; 176:75–84. - PMC - PubMed
1. Scott HM, Spinelli M, Vittinghoff E, et al. . Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics. AIDS 2019. doi:10.1097/QAD.0000000000002347. Epub ahead of print. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation

Affiliations

Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous